bezafibrate has been researched along with Inflammation in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (50.00) | 29.6817 |
| 2010's | 8 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brown, PJ; Henke, BR; Sternbach, DD; Willson, TM | 1 |
| Edwards, BS; Graves, SW; Saunders, MJ; Sklar, LA; Zhu, J | 1 |
| Kiem, PV; Kim, YH; Minh, CV; Ngan, NT; Quang, TH; Song, SB; Tai, BH; Thao, NP | 1 |
| Ebihara, N; Ouchi, Y; Usui-Ouchi, A | 1 |
| Behar, S; Benderly, M; Eisen, A; Goldbourt, U; Haim, M | 1 |
| Dushkin, MI; Khoshchenko, OM; Posokhova, EN; Schvarts, YSh | 1 |
| Krysiak, R; Okopien, B | 1 |
| Gdula-Dymek, A; Krysiak, R; Okopien, B | 2 |
| Beal, MF; Calingasan, NY; Chan, RB; Di Paolo, G; Dumont, M; Elipenahli, C; Gerges, M; Jainuddin, S; Pujol, A; Stack, C; Starkov, AA; Starkova, N; Tampellini, D; Yang, L | 1 |
| Tesfaigzi, Y | 1 |
| Foster, JE; Gott, K; Kozak, W; Schuyler, MR; Tesfaigzi, Y | 1 |
| Kohno, H; Sugie, S; Suzuki, R; Tanaka, T | 1 |
| Ikewaki, K; Kido, T; Mochizuki, S; Noma, K; Tohyama, J | 1 |
| Adler, Y; Behar, S; Boyko, V; Feinberg, M; Fisman, EZ; Lapidot, M; Matas, Z; Motro, M; Schwammenthal, E; Tanne, D; Tenenbaum, A; Tenenbaum, H | 1 |
| Jonkers, IJ; Mohrschladt, MF; Smelt, AH; van der Laarse, A; Westendorp, RG | 1 |
2 review(s) available for bezafibrate and Inflammation
| Article | Year |
|---|---|
The PPARs: from orphan receptors to drug discovery.
Topics: Animals; Diabetes Mellitus; Drug Design; Humans; Hyperlipidemias; Hypertension; Inflammation; Ligands; Models, Molecular; Neoplasms; Nuclear Proteins; Obesity; Receptors, Cytoplasmic and Nuclear; Transcription Factors | 2000 |
The role of apoptotic regulators in metaplastic mucous cells.
Topics: Allergens; Animals; Apoptosis; bcl-2-Associated X Protein; bcl-X Protein; Bezafibrate; Cell Division; Endotoxins; Epithelial Cells; Exocrine Glands; Genes, bcl-2; Goblet Cells; Inflammation; Inflammation Mediators; Lipopolysaccharides; Metaplasia; Mucous Membrane; Ozone; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Inbred BN; Smoke | 2002 |
5 trial(s) available for bezafibrate and Inflammation
| Article | Year |
|---|---|
Inflammation and future risk of symptomatic heart failure in patients with stable coronary artery disease.
Topics: Age Factors; Aged; Bezafibrate; Biomarkers; C-Reactive Protein; Coronary Artery Disease; Female; Fibrinogen; Follow-Up Studies; Heart Failure; Humans; Hypolipidemic Agents; Incidence; Inflammation; Israel; Leukocyte Count; Male; Middle Aged; Risk Factors; Time Factors | 2014 |
Monocyte-suppressing effect of bezafibrate but not omega-3 fatty acids in patients with isolated hypertriglyceridaemia.
Topics: Bezafibrate; C-Reactive Protein; Cytokines; Fatty Acids, Omega-3; Female; Humans; Hypertriglyceridemia; Hypolipidemic Agents; Inflammation; Insulin Resistance; Male; Middle Aged; Monocytes | 2011 |
The effect of bezafibrate and omega-3 fatty acids on lymphocyte cytokine release and systemic inflammation in patients with isolated hypertriglyceridemia.
Topics: Adult; Aged; Bezafibrate; C-Reactive Protein; Cholesterol; Cytokines; Fatty Acids, Omega-3; Female; Humans; Hypertriglyceridemia; Hypolipidemic Agents; Inflammation; Lymphocytes; Male; Middle Aged; Treatment Outcome; Triglycerides | 2011 |
Long-term effect of bezafibrate on pancreatic beta-cell function and insulin resistance in patients with diabetes.
Topics: Aged; Bezafibrate; Blood Glucose; Diabetes Mellitus, Type 2; Disease Progression; Female; Follow-Up Studies; Homeostasis; Humans; Hypolipidemic Agents; Inflammation; Insulin Resistance; Insulin-Secreting Cells; Lipids; Male; Middle Aged; Placebos | 2007 |
Severe hypertriglyceridemia with insulin resistance is associated with systemic inflammation: reversal with bezafibrate therapy in a randomized controlled trial.
Topics: Bezafibrate; Blood Glucose; C-Reactive Protein; Cross-Over Studies; Double-Blind Method; Female; Fibrinogen; Humans; Hypertriglyceridemia; Hypolipidemic Agents; In Vitro Techniques; Inflammation; Inflammation Mediators; Insulin; Insulin Resistance; Interleukin-6; Lipids; Male; Middle Aged; Tumor Necrosis Factor-alpha | 2002 |
9 other study(ies) available for bezafibrate and Inflammation
| Article | Year |
|---|---|
Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
Topics: Animals; Biotinylation; Flow Cytometry; Fluorescence Resonance Energy Transfer; Green Fluorescent Proteins; High-Throughput Screening Assays; Humans; Inflammation; Kinetics; Microspheres; Peptide Hydrolases; Peptides; Reproducibility of Results; Temperature | 2010 |
Anti-inflammatory and PPAR transactivational effects of secondary metabolites from the roots of Asarum sieboldii.
Topics: Anti-Inflammatory Agents; Asarum; Cyclooxygenase 2; Dose-Response Relationship, Drug; Furans; Hep G2 Cells; Humans; Inflammation; Magnetic Resonance Spectroscopy; Mass Spectrometry; NF-kappa B; Nitric Oxide Synthase Type II; Phenols; Plant Roots; PPAR alpha; Republic of Korea; Transcription, Genetic; Transcriptional Activation; Tumor Necrosis Factor-alpha | 2012 |
The peroxisome proliferator-activated receptor pan-agonist bezafibrate suppresses microvascular inflammatory responses of retinal endothelial cells and vascular endothelial growth factor production in retinal pigmented epithelial cells.
Topics: Anti-Inflammatory Agents; Bezafibrate; Cells, Cultured; Chemokine CCL2; Diabetic Retinopathy; Endothelial Cells; Humans; Inflammation; NF-kappa B; Peroxisome Proliferator-Activated Receptors; Retina; Retinal Pigment Epithelium; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1; Vascular Endothelial Growth Factor A | 2017 |
Agonists of PPAR-alpha, PPAR-gamma, and RXR inhibit the formation of foam cells from macrophages in mice with inflammation.
Topics: Alitretinoin; Animals; Bezafibrate; Cholesterol; Cholesterol Esters; Foam Cells; Inflammation; Injections, Intraperitoneal; Macrophages, Peritoneal; Male; Mice; Mice, Inbred C57BL; PPAR alpha; PPAR gamma; Retinoid X Receptors; Rosiglitazone; Thiazolidinediones; Tretinoin; Triglycerides; Tumor Necrosis Factor-alpha; Zymosan | 2007 |
Effect of bezafibrate on monocyte cytokine release and systemic inflammation in patients with impaired fasting glucose.
Topics: Bezafibrate; Blood Glucose; Case-Control Studies; Cytokines; Dyslipidemias; Female; Humans; Inflammation; Male; Middle Aged; Models, Biological; Monocytes | 2011 |
Bezafibrate administration improves behavioral deficits and tau pathology in P301S mice.
Topics: Adipose Tissue, Brown; Animals; Behavior, Animal; Bezafibrate; Disease Models, Animal; Energy Metabolism; Fatty Acids; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Inflammation; Mice; Mice, Transgenic; Oxidation-Reduction; Oxidative Stress; Phosphorylation; tau Proteins; Tauopathies | 2012 |
LPS-induced neutrophilic inflammation and Bcl-2 expression in metaplastic mucous cells.
Topics: Animals; Bezafibrate; Bronchoalveolar Lavage Fluid; DNA Primers; Dose-Response Relationship, Drug; Genes, bcl-2; Hypolipidemic Agents; Inflammation; Lipopolysaccharides; Macrophages, Alveolar; Male; Metaplasia; Neutrophils; Polymerase Chain Reaction; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Inbred BN; Rats, Inbred F344; Time Factors; Transcription, Genetic | 2003 |
Suppression of colitis-related mouse colon carcinogenesis by a COX-2 inhibitor and PPAR ligands.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Bezafibrate; Body Weight; Chromans; Colitis; Colonic Neoplasms; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Female; Hypolipidemic Agents; Immunohistochemistry; Inflammation; Injections, Intraperitoneal; Ligands; Male; Mice; Mice, Inbred ICR; Nitric Oxide Synthase Type II; Organ Size; Peroxisome Proliferator-Activated Receptors; Sulfonamides; Temperature; Thiazolidinediones; Troglitazone; Tyrosine; Vasodilator Agents | 2005 |
Effects of bezafibrate on lipoprotein subclasses and inflammatory markers in patients with hypertriglyceridemia--a nuclear magnetic resonance study.
Topics: Bezafibrate; Body Mass Index; C-Reactive Protein; Chemokine CCL2; Cholesterol, HDL; Cholesterol, VLDL; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Humans; Hypertriglyceridemia; Hypolipidemic Agents; Inflammation; Interleukin-6; Lipoproteins; Lipoproteins, HDL; Lipoproteins, HDL3; Lipoproteins, LDL; Magnetic Resonance Spectroscopy; Male; Middle Aged; Nephelometry and Turbidimetry; Risk Factors; Triglycerides | 2005 |